[caption id="attachment_343" align="alignleft" width="238"] Courtesy of www.money.cnn.com via Google Images.[/caption] Last Wednesday at McKesson Corporation’s annual stockholders meeting, the majority of investors voted to strengthen the company’s clawback policy. With the support of proxy advisory firms, the non-binding proposal stated the company’s existing policy possesses too...
Read More[caption id="attachment_333" align="alignleft" width="178"] Courtesy of via www.scientificamerican.com Google Images.[/caption] Are investors only interested in Vertex Pharmaceuticals (VRTX) because of its cystic fibrosis drug program? We’re about to find out. After the stock exchange closed Thursday, the company announced a partial clinical hold on its first...
Read More[caption id="attachment_295" align="alignleft" width="363"] Courtesy of www.politico.com via Google Images.[/caption] Stocks in the health care sector have outperformed the 2013 Dow Jones thus far. For every dollar gained in the overall market index, the health care indices have gained $1.50. Aside from monetary growth, health care...
Read More
One successful or lackluster drug can make or break small and mid-sized pharmaceutical ventures. Savvy development strategies and an efficient pipeline are a must in this competitive sector. Ironwood Pharmaceutical has used their industry knowledge to build partnerships and develop drugs with a high probability for...
Read More